pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    NVPLC-2767
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… NVP Healthcare Co Ltd
  • Preclinical
    NVX-101
    rifampicin
    Age Related Macular Degeneration NeoVascularX Inc
  • Phase 2
    NVX-108
    perflenapent
    Glioblastoma Multiforme (GBM) NuvOx Pharma LLC
  • Phase 1
← prev
page 115 of 231
next →
131
Pain89
Neurology1
NX-1607
Adenocarcinoma Of The Gastroesophageal Junction
$NRIX Nurix Therapeutics, Inc.
  • Phase 2
    NX-210c
    Amyotrophic Lateral Sclerosis Axoltis Pharma SAS
  • Phase 1
    NXP-900
    Cervical Cancer$NVCT Nuvectis Pharma, Inc.
  • NYPOZI TXID
    NYPOZI TXID (FILGRASTIM-TXID)
    no indication Tanvex BioPharma USA Inc
  • NYSTATIN AND TRIAMCINOLONE ACETONIDE
    NYSTATIN AND TRIAMCINOLONE ACETONIDE
    no indication SUN PHARMA CANADA
  • NYSTATIN CREAM
    NYSTATIN CREAM
    no indication CROWN LABS INC
  • NYVEPRIA
    NYVEPRIA (PEGFILGRASTIM-APGF)
    no indication Hospira Inc
  • Phase 2
    NanoDOX
    NanoDOX
    Wounds Resilience Government Services Inc
  • Preclinical
    Nanoapalutamide
    Prostate Cancer Nanoform Finland Plc
  • Preclinical
    Nanoparticle Mesothelin MOTO-CAR
    Solid Tumor Thunder Biotech Inc
  • Preclinical
    Nephron Progenitor Cells (Auto)
    Chronic Kidney Disease (Chronic Renal Failure) Jikei University School of Medicine
  • Preclinical
    Nephron Progenitor Cells (Organ) (Allo iPS Cell-Based Induced)
    Renal Failure Sumitomo Pharma Co Ltd
  • Phase 2
    Nerofe
    Nerofe
    Refractory Acute Myeloid Leukemia Immune System Key Ltd
  • Phase 3
    Neuronata-R
    Amyotrophic Lateral Sclerosis Corestemchemon Inc
  • Preclinical
    Next-generation CAR-T
    Ovarian Cancer ToolGen Inc
  • Phase 1
    Nezavist
    Alcohol Use Disorder (AUD) Lohocla Research Corp
  • Preclinical
    Niemann-Pick Type C
    Niemann-Pick Disease Type C U.S. National Institutes of Health
  • Marketed
    Nizoral
    Ketoconazole Patriot (ketoconazole)
    Pityriasis Simplex Capillitii (Dandruff) Patriot Pharmaceuticals LLC
  • Preclinical
    No Alpha IL-2 Mutein
    Unspecified Cancer Roswell Park Cancer Institute
  • Phase 2
    Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
    Norovirus Infections$VXRT Vaxart, Inc.
  • Marketed
    Norpace
    Norpace (disopyramide phosphate)
    Ventricular Arrhythmia$PFE PFIZER INC
  • Phase 2
    NouvNeu-001
    Parkinson's Disease iRegene Therapeutics Co Ltd
  • Preclinical
    NouvSight-001
    Diabetic Retinopathy iRegene Therapeutics Co Ltd
  • Phase 2
    Nov-DB2
    Obesity NovMetaPharma Co Ltd
  • Preclinical
    NovAD
    NovAD
    Alzheimer's Disease NovMetaPharma Co Ltd
  • Phase 2
    NovOB
    Obesity NovMetaPharma Co Ltd
  • Preclinical
    Novel Drug to Undisclosed Target
    Crohn's Disease (Regional Enteritis)$VIVS VivoSim Labs, INC.